Podocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0319424 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Liming Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Podocytes, Glomerulosclerosis, Focal Segmental, Receptors, Atrial Natriuretic Factor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Natriuretic peptides (NPs) bind to glomerular podocytes and attenuate glomerular injury. The beneficial effects of NPs are negatively regulated by the NP clearance receptor (NPRC), which is highly expressed in podocytes. To determine if inhibiting NPRC is podocyte protective, we examined the effects of deleting NPRC in both cultured podocytes and in vivo. We found that: 1.Both atrial NP and C-type NP inhibit podocyte apoptosis in cultured podocytes, but these podocyte protective effects are significantly attenuated in cells expressing NPRC, and 2. Atrial NP was significantly more effective than CNP at inhibiting the apoptotic response. Consistent with the protective actions of NPs, podocyte specific knockout of NPRC reduced albuminuria, glomerular sclerosis and tubulointerstitial inflammation in a mouse model of focal segmental glomerulosclerosis. These beneficial actions were associated with: 1. Decreased expression of the myofibroblast marker alpha-smooth muscle actin, 2. Reduced expression of the extracellular matrix proteins collagen 4-alpha-1 and fibronectin, and 3. Preserved expression of the podocyte proteins nephrin and podocin. Inhibiting NP clearance may be a useful therapeutic approach to treat glomerular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, North Carolina, United States of America.
- Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America.
ORCID-Profile: Robert F Spurney
Förderung
- BLRD VA
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- U.S. Department of Defense
- U.S. Department of Veterans Affairs
Zitieren
APA
Wang, L., Tang, Y., Buckley, A. F., & Spurney, R. F. (2025). Podocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0319424
Vancouver
Wang L, Tang Y, Buckley AF, Spurney RF. Podocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis. PLOS ONE. 2025. doi:10.1371/journal.pone.0319424
BibTeX
@article{Wang2025,
author = {Wang, Liming and Tang, Yuping and Buckley, Anne F and Spurney, Robert F},
title = {Podocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0319424}
}
EUVIMED